Drugs.com - Pharma Industry News

Certain Glucose-Lowering Meds Associated With Lower Risk for COPD Exacerbations

FRIDAY, Feb. 21, 2025 -- For patients with type 2 diabetes (T2D) and chronic obstructive pulmonary disorder (COPD), sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with a...

Feb 21, 2025 - 18:46
 0
Certain Glucose-Lowering Meds Associated With Lower Risk for COPD Exacerbations
FRIDAY, Feb. 21, 2025 -- For patients with type 2 diabetes (T2D) and chronic obstructive pulmonary disorder (COPD), sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with a...
Read More

Tags:

Previous Article

Olpasiran Leads to Significant Reduction in Oxidized Phospholipids

Next Article

Sisters of Those With Adverse Pregnancy Outcome Also Have Increased CVD Risk

Related Posts

AI-Assisted Screening Tool Speeds Trial Eligibility Determination

AI-Assisted Screening Tool Speeds Trial Eligibility Det...

Feb 24, 2025  0

Eightfold Increase in Wildfire-Linked ED Encounters Seen With Onset of LA Wildfires

Eightfold Increase in Wildfire-Linked ED Encounters See...

Feb 9, 2025  0

In 2023, 1.4 Percent of U.S. Children Ever Experienced Post-COVID Condition

In 2023, 1.4 Percent of U.S. Children Ever Experienced ...

Feb 12, 2025  0